Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779558 · ClinicalTrials.gov registry record · NA
Heparin and the Reduction of Thrombosis (HART) Trial
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00779558: Completed NA study, sponsored by Stanford University.
NCT00779558 is a NA study that has completed, run by Stanford University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00779558, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?
Primary Outcome
Echocardiographic evidence of thrombosis while on study drug
Interventions
- DRUG Placebo infusion
- DRUG Heparin sulfate infusion at 10 units/kg/hour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00779558 record still lists
NCT00779558 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo infusion is the first listed.
NCT00779558 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00779558 about?
NCT00779558 is a clinical study titled "Heparin and the Reduction of Thrombosis (HART) Trial". Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units...
What is the current status of trial NCT00779558?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2005-11. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00779558?
The interventions under investigation include: Placebo infusion (DRUG), Heparin sulfate infusion at 10 units/kg/hour (DRUG).
Who is sponsoring clinical trial NCT00779558?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00779558's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia